{{Short description|Estrogen medication}}
{{Distinguish|Estrogen (medication)|Estrone (medication)}}
{{Drugbox
| image = Estron.svg
| width = 225px
| caption = Estrone, a major ingredient in estrogenic substances

<!--Combo data-->
| type = combo
| drug_name = Estrogenic substances
| component1 = Estrone
| class1 = [[Estrogen (medication)|Estrogen]]
| component2 = 17β-Estradiol
| class2 = [[Estrogen (medication)|Estrogen]]
| component3 = Equilin
| class3 = [[Estrogen (medication)|Estrogen]]

<!-- Clinical data -->
| tradename = Amniotin, Estrogenic Hormones, Estrogenic Substances, Estrolin, Estromone, Folestrin, Follacro, Menformon, Oestroform, Ova-Estrin, Theelestrin, others
| Drugs.com = 
| MedlinePlus = 
| pregnancy_AU = <!-- A, B1, B2, B3, C, D, X -->
| pregnancy_US = <!-- A, B, C, D, X -->
| pregnancy_category = 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
<!-- OTC, Rx-only, Schedule I, II, III, IV, V -->
| legal_US = Rx-only
| routes_of_administration = [[Oral administration|By mouth]] ([[tablet (pharmacy)|tablet]]s, [[capsule (pharmacy)|capsule]]s), [[topical administration|topical]] ([[ointment]]), [[vaginal administration|vaginal]] ([[suppository]]), [[intramuscular injection]] ([[oil solution]])
| class = [[Estrogen (medication)|Estrogen]]

<!-- Identifiers -->
| CAS_number = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 
| DrugBank = 
| synonyms = Natural estrogens; Estrone-like preparations
}}

'''Estrogenic substances''', also referred to as '''natural estrogens''' and sold under the brand name '''Amniotin''' among others, is an [[estrogen (medication)|estrogen]] medication which was marketed in the 1930s and 1940s and is no longer available.<ref name="JAMA1943">{{cite journal|title=Nomenclature of Endocrine Preparations|journal=Journal of the American Medical Association|volume=123|issue=6|year=1943|pages=351|issn=0002-9955|doi=10.1001/jama.1943.02840410033009}}</ref><ref name="pmid18744783">{{cite journal | vauthors = Fluhmann CF | title = Estrogenic Hormones: Their Clinical Usage | journal = California and Western Medicine | volume = 49 | issue = 5 | pages = 362–366 | date = November 1938 | pmid = 18744783 | pmc = 1659459 }}</ref><ref name="Greene1941">{{cite journal| vauthors = Greene RR |title=Endocrine Therapy for Gynecologic Disorders|journal=Medical Clinics of North America|volume=25|issue=1|year=1941|pages=155–168|issn=0025-7125|doi=10.1016/S0025-7125(16)36624-X}}</ref><ref name="Fluhmann1944">{{cite journal| vauthors = Fluhmann CF |title=Clinical use of extracts from the ovaries|journal=Journal of the American Medical Association|volume=125|issue=1|year=1944|pages=1|issn=0002-9955|doi=10.1001/jama.1944.02850190003001}}</ref><ref name="Reifenstein1944">{{cite journal| vauthors = Reifenstein EC |title=Endocrinology: A Synopsis of Normal and Pathologic Physiology, Diagnostic Procedures, and Therapy|journal=Medical Clinics of North America|volume=28|issue=5|year=1944|pages=1232–1276|issn=0025-7125 |doi=10.1016/S0025-7125(16)36180-6}}</ref><ref name="GoldzieherGoldzieher1953">{{cite book| vauthors = Goldzieher MA, Goldzieher JW |title=Endocrine Treatment in General Practice|url=https://books.google.com/books?id=vdH8Dt1NujoC&pg=PA436 |year=1953|publisher=Springer Publishing Company|pages=436–}}</ref> It was a purified [[extract]] of [[animal material]] such as horse [[urine]], [[placenta]], and/or [[amniotic fluid]], and contained a non-[[crystalline]] [[mixture]] of estrogens, including [[estrone (medication)|estrone]], [[estradiol (medication)|17β-estradiol]], [[alfatradiol|17α-estradiol]], and/or [[equilin]].<ref name="Greene1941" /><ref name="JAMA1943" /><ref name="Barr1940" /><ref name="AMA1935" /><ref name="Reifenstein1944" /><ref name="McCullagh1935">{{cite journal | vauthors = McCullagh EP | title = The Management of Functional Menstrual Disorders | journal = Cleveland Clinic Quarterly | year = 1935 | volume = 2 | issue = 4 | pages = 52–64 | doi = 10.3949/ccjm.2.4.52| url = https://www.mdedge.com/ccjm/article/90505/management-functional-menstrual-disorders}}</ref> The medication was thought to contain estrone as its major active ingredient<ref name="Barr1940">{{cite book| vauthors = Barr DP |title=Modern Medical Therapy in General Practice |url=https://books.google.com/books?id=V5HJymGfFP8C |year=1940 |publisher=William & Wilkins Company |isbn=9780598668332 |quote=Complex Estrogenic Preparations. 1. Amniotin (Squibb). This is a highly purified but not crystalline preparation derived from pregnant mares' urine. The chief active ingredient is apparently ketohydroxyestrin (estrone).}}</ref> and was described as an estrone-like preparation, or as "essentially estrone".<ref name="JAMA1943" /><ref name="Greene1941" /><ref name="Reifenstein1944" /> Estrogenic substances was originally produced from the urine of pregnant women, placenta, and/or amniotic fluid, but by the early 1940s, it was manufactured exclusively from the urine of [[stallion]]s or pregnant [[mare]]s, similarly to almost all other estrogen preparations on the market.<ref name="AMA1935">{{cite book|title=Glandular Physiology and Therapy|url=https://books.google.com/books?id=HKlFAAAAYAAJ|year=1935|publisher=American Medical Association|page=480|quote=Amniotin, E. R. Squibb & Sons: This is an estrogenic preparation originally derived from amniotic fluid; it is not reduced to the crystalline state during manufacture. More recently, according to the firm, the urine of pregnant mares has served as an added source of active material.}}</ref><ref name="McCullagh1935" /><ref name="Barr1940" /><ref name="JAMA1943" />

Estrogenic substances was marketed under a variety of different brand names including ''Amniotin'' ([[Bristol-Myers Squibb|Squibb]]), ''Equine Estrogenic Substances'' (Ayerst), ''Estrogenic Hormones'' ([[Upjohn]], others), ''Estrogenic Substances'' (Reed & Carnrick, Sharp & Dohme, others), ''Estrolin'' (Lakeside), ''Estromone'', ''Estronat'' (National Drug), ''Folestrin'' ([[Armour and Company|Armour]]), ''Follacro'' (Schieffelin), ''Menformon'' ([[Hoffmann-La Roche|Roche]]-[[Organon International|Organon]]), ''Neo-Amniotin'' (Squibb), ''Oestroform'', ''Ova-Estrin'', ''Theelestrin'', and ''Urestrin'' (Upjohn), among others.<ref name="JAMA1943" /><ref name="pmid18744783" /><ref name="Greene1941" /><ref name="Fluhmann1944" /><ref name="GoldzieherGoldzieher1953" /> It was provided in various [[pharmaceutical form|form]]s and [[route of administration|routes of administration]] including [[oil solution]] and [[aqueous suspension]] for [[intramuscular injection]], [[oral administration|oral]] [[tablet (pharmacy)|tablet]]s and [[capsule (pharmacy)|capsule]]s, [[vaginal administration|vaginal]] [[suppository|suppositories]], and [[topical administration|topical]] [[ointment]]s.<ref name="pmid18744783" /><ref name="Greene1941" /><ref name="Fluhmann1944" /><ref name="JAMA1943" /><ref name="GoldzieherGoldzieher1953" />

Estrogen medications similar to but distinct from estrogenic substances included [[conjugated estriol]] (''Emmenin'') and [[conjugated estrogens]] (''Premarin'').<ref name="JAMA1943" /> They are also non-crystalline mixtures of estrogens.<ref name="JAMA1943" /> Estrogenic substances were also distinct from pure crystalline preparations such as [[estrone (medication)|estrone]], [[estradiol (medication)|estradiol]], [[estriol (medication)|estriol]], [[estradiol benzoate]], and [[estradiol dipropionate]].<ref name="JAMA1943" /> The medication should additionally be distinguished from estrogen [[ovary|ovarian]] extracts, which had little activity and were considered to be essentially inactive.<ref name="Novak1935">{{cite journal | vauthors = Novak E |title=The Therapeutic Use of Estrogenic Substances|journal=JAMA: The Journal of the American Medical Association|volume=104|issue=20|year=1935|pages=1815|issn=0098-7484|doi=10.1001/jama.1935.92760200002012}}</ref><ref name="pmid18744783" />

[[Progynon]] and Amniotin were both marketed by 1929.<ref name="Thomas1929">{{cite book|title=The Female Sex Hormone|url=https://books.google.com/books?id=UBM_AQAAIAAJ|year=1929|publisher=C.C. Thomas|page=276}}</ref> Amniotin was originally prepared from the amniotic fluid of cattle, but was later prepared using other sources such as the urine of pregnant mares.<ref name="Biskind1935">{{cite journal| vauthors = Biskind MS|title=Commercial glandular products|journal=Journal of the American Medical Association|volume=105|issue=9|year=1935|pages=667|issn=0002-9955|doi=10.1001/jama.1935.92760350007009a}}</ref><ref name="McCullagh1935" />

== References ==
{{Reflist}}

{{Estrogens and antiestrogens}}
{{Estrogen receptor modulators}}

[[Category:Abandoned drugs]]
[[Category:Combination sex hormone drugs]]
[[Category:Estrogens]]
[[Category:Horse products]]